Two thirds of healthcare workers who have died from covid-19 were from an ethnic minority background, and at […]

The reason I write this letter is to take a small step towards helping readers with evidence based […]

Safety of new treatments for multiple sclerosisImmunomodulating treatments help people with multiple sclerosis by reducing relapse rate and […]

Critics of covid-19 management say that something should have been done weeks before it was,1 forgetting that most […]

DARE-19 will determine whether Farxiga can hold back disease progression and reduce the risk of clinical complications and […]

Forty percent of pharmacists surveyed said they were unable to maintain social distancing from patients

The decision ensures that the merger between Mylan and Upjohn does not harm competition

REACH2 is the first Phase III study in steroid-refractory acute graft-versus-host-disease (GvHD) to have met its primary endpoint

Laboratories and laboratory technology are perhaps the most important component of today’s medicine – they save and secure […]

Imagine a Fitbit that measures much more than steps, heart rate, and calories burned. It continually tracks all […]